Dorofen and Anadar are pharmaceutical agents used in the management of osteoarthritis, a degenerative joint disease characterized by the breakdown of cartilage and underlying bone. This condition leads to pain, stiffness, and reduced mobility, significantly affecting the quality of life for those affected.